The Search for a Mesothelioma Cure
Although there is currently no cure for mesothelioma, there are new developments in early detection, prevention and treatment.
Research That Leads to a Cure
How is Mesothelioma Treatment Progressing?
With newly developed treatments, the average life expectancy of a mesothelioma patient has improved ten-fold in the past 2 decades.
Researchers across the globe are involved in new trials aimed at early detection and treatments that help patients live longer.
More Treatment Options
There are 2 times the number of treatment options available as there were a decade ago.
There is also genomic research being conducted on the relationship of genetics and the development of mesothelioma. Researchers have found that some genes contain information in declaring when our cells grow and at what rate they grow.
Over the past two decades, many experimental therapies have emerged. This is partially due to the growing number of mesothelioma-focused clinical trials. While some of these therapies still require additional testing, the groundwork is in place for patients to benefit from them in the future. These treatments may lead to a cure.
Find Clinical Trials and Emerging Treatments
What Can You Get From Clinical Trials?
- You’ll have access to new treatments not available to the general public.
- Join survivors such as Kendra Ferreira, who has outlived her prognosis by more than 10 years thanks to a clinical trial.
- One-on-one care from America’s leading mesothelioma specialists and researchers.
The first is active immunotherapy, which uses medication to enhance the immune system. The other is passive immunotherapy, which adds laboratory-created proteins to what the body is currently lacking. Immunotherapy is currently in clinical trials to determine its effectiveness, reliability and repeatability.
The drug Avastin has recently become the first of its kind to introduce antibodies in an attempt to treat cancer and extend life. In 2012, one the largest clinical trials centered on immunotherapy began. Its purpose is to develop a pipeline of continual phase 3 clinical trials.
Researchers have found that immunotherapy is one of the most promising forms of therapy for mesothelioma patients. For certain forms of immunotherapy, like dendritic cell-based immunotherapy, cells are stimulated outside the body and then reinserted into the body attached to non-active virus.
These cells are programmed to attack the cancerous cells. Immunotherapy is being used in large cell lung cancer and mesothelioma, bringing to light possible treatments for later staged cancer patients, and hopefully an eventual mesothelioma cure.
Get involved in clinical trials testing new immunotherapy treatments today.
There are several important benefits of genetic testing:
- Earlier Diagnosis: The most important benefit of genetic testing is that doctors may be able to diagnose patients earlier. Doctors can use genetic testing to screen their patients who have been exposed to asbestos for mutations that may cause mesothelioma.
- Personalized Treatment: Researchers are working to develop more personalized treatments for mesothelioma. New treatments are being created for patients with certain genes. Doctors can choose specific treatments based on their patient’s DNA.
- More Accurate Prognosis: Doctors can use a patient’s genetic makeup to give a more accurate prognosis. Genetic information can also help doctors decide which treatments will be effective in improving a patient’s prognosis.
Many cancers and illnesses are caused or affected by genetic mutations. Sometimes patients are born with these mutations but carcinogens, like asbestos, can alter DNA as well. Genetic testing can help doctors identify patients with the mutations that could cause mesothelioma.